13F Holdings
中文EN

CARL CARLSMED, INC.

Surgical & Medical Instruments & Apparatus · Nasdaq · SEC CIK 1794546 · Fiscal year ends 12/31

Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY60.4%
TTM net income YoY-55.6%
TTM EPS YoY65.7%
Revenue 3-yr CAGR—
Net income 3-yr CAGR—

Margins

Gross margin77.0%
Operating margin-59.0%
Net margin-55.8%
FCF margin-48.6%
EBITDA margin-58.4%

Returns

ROE-43.9%
ROA-32.0%
ROIC (approx.)-108.1%
Asset turnover0.57x

Leverage & solvency

Liabilities / assets34.4%
Debt / equity0.20x
Current ratio5.79x
Interest coverage-33.33x

Cash quality & payout

Operating cash flow / net income0.86x
Accruals ratio-4.6%
Payout ratio—
Capex / revenue0.8%

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item FY20252025-12-31FY20242024-12-31
Income statement
Revenue$50.51M$27.16M
Cost of revenue$12.47M$7.12M
Gross profit$38.04M$20.05M
R&D expense$17.02M$14.30M
SG&A expense$16.57M$8.39M
Operating income-$30.57M-$24.12M
Interest expense$1.43M$1.32M
Income tax$0$0
Net income-$29.63M-$24.26M
EBITDA-$30.29M-$23.98M
EPS (basic)-2.12-6.11
EPS (diluted)-2.12-6.11
Weighted avg. shares (diluted)14.22M4.07M
Balance sheet
Cash & equivalents$85.79M$40.12M
Short-term investments$24.00M$0
Receivables$11.36M$6.77M
Inventory$1.84M$995,000
Current assets$126.67M$49.35M
PP&E, net$1.49M$260,000
Total assets$130.12M$51.82M
Current liabilities$14.28M$8.82M
Long-term debt$15.35M$15.41M
Total debt$15.35M$15.41M
Total liabilities$31.25M$26.23M
Shareholders' equity$98.87M-$70.63M
Net debt-$70.45M-$24.71M
Shares outstanding26.60M4.14M
Cash flow statement
Operating cash flow-$28.98M-$25.47M
Capital expenditure$642,000$180,000
Free cash flow-$29.62M-$25.65M
Investing cash flow-$25.48M-$180,000
Financing cash flow$100.13M$58.50M
Depreciation & amortization$281,000$145,000
Stock-based compensation$1.93M$253,000

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.